BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 24978674)

  • 1. Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
    Gianatti EJ; Dupuis P; Hoermann R; Zajac JD; Grossmann M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3821-8. PubMed ID: 24978674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
    Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
    Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial.
    Seidman SN; Roose SP
    J Sex Marital Ther; 2006; 32(3):267-73. PubMed ID: 16809253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
    Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM
    BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of testosterone replacement treatment on constitutional and sexual symptoms in type 2 diabetic men: need for rules.
    Dimitriadis F; Sofikitis N
    Asian J Androl; 2015; 17(2):217-8. PubMed ID: 25432496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study).
    Buvat J; Montorsi F; Maggi M; Porst H; Kaipia A; Colson MH; Cuzin B; Moncada I; Martin-Morales A; Yassin A; Meuleman E; Eardley I; Dean JD; Shabsigh R
    J Sex Med; 2011 Jan; 8(1):284-93. PubMed ID: 20704642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study.
    Melehan KL; Hoyos CM; Yee BJ; Wong KK; Buchanan PR; Grunstein RR; Liu PY
    Andrology; 2016 Jan; 4(1):55-61. PubMed ID: 26610430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes.
    Gianatti EJ; Hoermann R; Lam Q; Dupuis P; Zajac JD; Grossmann M
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):55-62. PubMed ID: 26120052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial.
    Paduch DA; Polzer PK; Ni X; Basaria S
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2956-62. PubMed ID: 26158605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA; Boneva Z; Christov VG
    Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tribulus terrestris versus placebo in the treatment of erectile dysfunction: A prospective, randomized, double blind study.
    Santos CA; Reis LO; Destro-Saade R; Luiza-Reis A; Fregonesi A
    Actas Urol Esp; 2014 May; 38(4):244-8. PubMed ID: 24630840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.
    Basaria S; Harman SM; Travison TG; Hodis H; Tsitouras P; Budoff M; Pencina KM; Vita J; Dzekov C; Mazer NA; Coviello AD; Knapp PE; Hally K; Pinjic E; Yan M; Storer TW; Bhasin S
    JAMA; 2015 Aug; 314(6):570-81. PubMed ID: 26262795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.
    Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H
    J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.